A conservative Republican U.S. senator spoke about the “possible benefits of medical marijuana as an alternative to opioids” on the Senate floor on Wednesday afternoon, and introduced bipartisan legislation aimed at expanding cannabis research.
Sen. Orrin Hatch, who has represented Utah in Congress since 1977, has historically not been a champion of marijuana law reform, and continues to oppose full recreational legalization.
But in a floor speech he said that “in our zeal to enforce the law, we too often blind ourselves to the medicinal benefits of natural substances like cannabis.”
“While I certainly do not support the use of marijuana for recreational purposes, the evidence shows that cannabis possesses medicinal properties that can truly change people’s lives for the better,” the senator said. “And I believe, Mr. President, that we would be remiss if we threw out the baby with the bathwater.”
Hatch’s new bill, the Marijuana Effective Drug Study (MEDS) Act of 2017 would ease researchers’ access to marijuana for studies on its medical benefits and would require the National Institute on Drug Abuse (NIDA) to develop recommendations for good manufacturing practices for growing and producing cannabis for research.
In a pun-filled statement about the legislation, Hatch said it is “high time to address research into medical marijuana,” adding:
“Our country has experimented with a variety of state solutions without properly delving into the weeds on the effectiveness, safety, dosing, administration and quality of medical marijuana. All the while, the federal government strains to enforce regulations that sometimes do more harm than good. To be blunt, we need to remove the administrative barriers preventing legitimate research into medical marijuana, which is why I’ve decided to roll out the MEDS Act.”
Sens. Brian Schatz (D-HI), Chris Coons (D-DE), Cory Gardner (R-CO) and Thom Tillis (R-NC) are initial cosponsors of the bill.
In his floor remarks, Hatch spotlighted impediments to research that currently exist because of marijuana’s status under federal law.
“We lack the science to support use of medical marijuana products like CBD oils not because researchers are unwilling to do the work, but because of bureaucratic red tape and over-regulation,” he said. “Under current law, those who want to complete research on the benefits of medical marijuana must engage in a complex application process and interact with several federal agencies. These regulatory acrobatics can take researchers over a year, if not more, to complete. And the longer researchers have to wait, the longer patients have to suffer.”
Cannabis is currently classified under Schedule I of the Controlled Substances Act. That’s the most restrictive category, and is supposed to be reserved for drugs with no medical value and a high potential for abuse. Researchers have long complained that the classification creates additional hurdles that don’t exist for studies on other substances.
The Senate Appropriations Committee issued a report last week expressing concern about Schedule I’s research roadblocks.
There are several other pending marijuana bills in the Senate that would change federal laws to allow protections to people who use medical cannabis legally in accordance with state laws, but Hatch has not yet added his name as cosponsor of any of them. One such comprehensive bill has three Republican and three Democratic cosponsors.
Activists in Hatch’s home state of Utah are currently collecting signatures to qualify a medical cannabis ballot initiative for 2018. A recent poll found that 79% of the state’s likely voters support the concept.
Hatch is a member of the Church of Jesus Christ of Latter-day Saints, which is opposing the pending Utah ballot initiative.
“We believe that society is best served by requiring marijuana to go through further research and the FDA approval process that all other drugs must go through before they are prescribed to patients,” the Church said in a statement earlier this year.
While Hatch hasn’t revealed his position on the ballot measure, he did speak of a young Utah constituent who suffers from seizures and could benefit from medical cannabis.
“This poor family is seeking help, yearning for a way for their child to live a safe and healthy life,” he said. “Compounds found in marijuana could significantly mitigate the severity of my friend’s seizures and even help him lead a normal life. But current regulations prevent the development of any such treatment from going forward. So this young man is left to suffer.”
But despite Hatch’s support for research and acknowledgment of marijuana’s medical benefits, he isn’t exactly a fan of how many state laws regulate the drug.
“If we make medical marijuana accessible to those who really need it, we should not increase access to recreational marijuana, nor should we do anything to promote the industry that has developed around marijuana dispensaries,” he said, adding:
“Mr. President, the recreational marijuana industry has its fair share of budding entrepreneurs. But these men and women are in no way qualified to issue prescriptions or give any medical advice whatsoever to people suffering from chronic conditions. Only experienced medical professionals who have undergone years of education and formal training are qualified to consult patients seeking a marijuana-derived treatment. Only licensed professionals know how to accurately diagnose illnesses and use approved medical treatments to safely treat disease.”
The senator also expressed discomfort with the smoking of medical cannabis, saying he believes that “treatment options should focus on non-combustive forms of marijuana.”
Hatch introduced a similar marijuana research bill last year, but did not so clearly endorse cannabis’s medical potential in the related press release as he did in his floor remarks this time.
A growing body of research suggests that legal marijuana access is associated with reduced opioid addiction and overdose rates.
GOP Congressman: Legal Marijuana Has “Possibility To Create Jobs”
Legalizing marijuana might be a way to help lift rural areas of Virginia out of poverty, a Republican who represents part of the state in Congress says.
“The lands out in Southwest are conducive to be able to grow that for medicinal purposes, or whatever it is, for other research purposes, and even recreational use for some areas, if Virginia chooses to legalize it in that way,” Congressman Scott Taylor said on Wednesday. “And if Virginia goes that way I think there is the possibility to create jobs down in the Southwest.”
Taylor, who was answering a caller’s question during an appearance on C-SPAN’s Washington Journal, added that he supports letting states set their own cannabis laws without federal interference.
“I think we should decriminalize it and leave it up to the states,” he said. “I do believe it’s a state decision, not a federal decision.”
Taylor, a freshman member of Congress, is a cosponsor of a pending House bill to remove marijuana from the Controlled Substances Act.
“When I was in the state House we voted to legalize industrial hemp, which is also another product that would grow well in Southwest just as tobacco did,” Taylor added. “So I think there’s product there.”
Advocates believe that Virginia has a good chance of decriminalizing cannabis in 2018. Incoming Gov. Ralph Northam, A Democrat, spoke often about cannabis on the campaign trail, consistently describing criminalization’s impact in stark racial justice terms.
Republican Senate Majority Leader Tommy Norment has announced he will file a decriminalization bill when the new legislative session begins in January.
Vermont Will Legalize Marijuana Within Weeks, Officials Indicate
Vermont appears poised to become the next state to legalize marijuana. And, according to top elected officials, it is likely to do so within a matter of weeks.
Last week, House Speaker Mitzi Johnson, a Democrat, said she expects “it likely will pass in early January.” Days earlier, Gov. Phil Scott, a Republican, said he is “comfortable” signing a cannabis legalization bill into law in early 2018. And on Thursday, Senate President Pro Tempore Tim Ashe, a member of the Progressive Party, said he and his colleagues “look forward to working with the governor to make sure that that bill gets to the finish line.”
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Photo courtesy of M a n u e l.
Here’s What Jeff Sessions Discussed In Secret With Anti-Marijuana Activists
Last week, U.S. Attorney General Jeff Sessions held a behind-closed-doors meeting about marijuana with anti-legalization activists.
Now, thanks to the fact that Sessions inadvertently showed an agenda for the meeting to a TV camera that was in the room to capture introductions — along with some high-tech sleuthing — we know what the prohibitionists discussed in secret after reporters were kicked out.
A Twitter user with the handle @MentalMocean was able to enhance a screen capture of the document that Marijuana Moment posted.
The document appears to read:
Bertha Madras: Marijuana is not a substitute for opiates as a pain medication.
Dr. Hoover Adger: The harm from today’s marijuana.
Dr. Bob DuPont: The effect of marijuana on drugged driving.
David Evans: The role that the Food and Drug Administration can and should [obscured]
[obscured] The organizations you can speak for and what you and they are [obscured] people from recreational marijuana use.
[obscured] law enforcement thinks of the commercialization of [obscured] law enforcement would support an enforcement initiative.
[obscured] course of marijuana commercialization in the states if the [obscured] not intervene.
The enhanced photo makes clear that the anti-legalization activists made a concerted pitch during meeting to convince Sessions to launch a federal crackdown on states that have ended cannabis prohibition.
Can any tech wizards enhance this screen grab of an agenda that Jeff Sessions was holding before the start of a drug policy meeting today? pic.twitter.com/7FLvjj1AZd
— Tom Angell 🌳📰 (@tomangell) December 8, 2017
— Sam Gold (@MentalMocean) December 13, 2017
In attendance, according to video of the opening introductions captured by a pool photographer and posted by C-SPAN, were:
- Edwin Meese III, U.S. attorney general under the Reagan administration
- Kevin Sabet, president and CEO of Smart Approaches to Marijuana
- Bertha Madras, a former Office of National Drug Control Policy staffer and a member of President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis
- Robert DuPont, former director of the National Institute on Drug Abuse
- David Evans, executive director of the Drug Free Schools Coalition
- Dr. Hoover Adger, Johns Hopkins Hospital
“I think it’s a big issue for America, for the country, and I’m of the general view that this is not a healthy substance,” Sessions said at the beginning of the gathering. “I think that’s pretty clear. And then have the policy response that we and the federal government needs to be prepared to take and do so appropriately and with good sense.”
“I appreciate the opportunity to hear your analysis on marijuana and some of the related issues,” Sessions told the group. “I do believe, and I’m afraid, that the public is not properly educated on some of the issues related to marijuana. And that would be a matter that we could, all of us together, maybe be helpful in working on and that would allow better policy to actually be enacted.”
The group’s roundtable discussion itself, which took place after initial introductions, was closed to the press.
The gathering comes as the Justice Department’s overall position on marijuana policy remains uncertain. Sessions has in recent weeks sent mixed signals about his plans for federal marijuana enforcement under the Trump administration.
Last month, he testified before Congress that an Obama-era Justice Department memo that generally allows states to implement their own marijuana laws without interference remains in effect. But he separately told reporters at a briefing that his department is actively conducting talks about potential changes to the policy.
Photo courtesy of Gage Skidmore.
Politics2 months ago
This Obscure 45-Year-Old Federal Law Exempts State-Legal Marijuana
Politics2 weeks ago
Trump Administration Considering Marijuana Policy Changes, Sessions Says
Politics2 months ago
Former Surgeon General: Legalize Marijuana; Decrim Not Good Enough
Politics2 months ago
These States Will Probably Vote On Marijuana In 2018
Politics2 months ago
FDA To Review Medical Claims About Marijuana
Politics2 months ago
Marijuana Is A Big Issue In Next Month’s Elections
Politics4 weeks ago
New Sessions Memo: Does It Impact Marijuana?
Science & Health2 months ago
Psychologists Group Slams Barriers To Marijuana Research